1. Repositório Institucional - INCA
  2. Comunicação
  3. Revistas e Informes
  4. Informe INCA
  5. Informe INCA 2022
  6. Informe INCA 415
Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/6207
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-04-04T17:51:39Z-
dc.date.available2022-04-04T17:51:39Z-
dc.date.issued2022-01-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/6207-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.subjectCompostos Radiofarmacêuticospt_BR
dc.subjectRadiopharmaceuticalspt_BR
dc.subjectRadiofármacospt_BR
dc.subjectTumores Neuroendócrinos/diagnósticopt_BR
dc.subjectNeuroendocrine Tumors/diagnosispt_BR
dc.subjectTumores Neuroendocrinos/diagnósticopt_BR
dc.subjectPujatt, Priscilla Brunellipt_BR
dc.titleNovo radiofármaco ajudará no diagnóstico de tumores neuroendócrinos por PET-CTpt_BR
dc.title.alternativeInforme INCA 415pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 415

Files in This Item:
File Description SizeFormat 
Informe-INCA-2022-415-4-Novo-radiofarmaco-ajudara.pdf212.84 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.